Cargando…
Validation of (125)I-hCG as a marker for elimination of hCG and stability of (125)I-hCG after in vivo injection in humans
We have recently introduced (125)I-hCG as an elimination marker in patients with human chorionic gonadotrophin (hCG) producing testicular cancer. (125)I-hCG is a well-known reagent in clinical biochemistry and is used extensively in hCG assays. Previous studies have shown that the iodination process...
Autores principales: | Christensen, T B, Marqversen, J, Engbaek, F, Berger, P, Bacher, T, Maase, H von der |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363111/ https://www.ncbi.nlm.nih.gov/pubmed/10408403 http://dx.doi.org/10.1038/sj.bjc.6690566 |
Ejemplares similares
-
(125)I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer
por: Christensen, T B, et al.
Publicado: (1999) -
Biological functions of hCG and hCG-related molecules
por: Cole, Laurence A
Publicado: (2010) -
Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.
por: Mora, J., et al.
Publicado: (1996) -
hCG, the wonder of today's science
por: Cole, Laurence A
Publicado: (2012) -
Beta-hCG expression by bladder cancers.
por: Iles, R.
Publicado: (1992)